Combined pulmonary fibrosis and emphysema syndrome associated with ABCA3 mutations

European Respiratory Journal

Volumn 43, Issue 2, 2014, Pages 638-641

  Epaud, Ralph ^a,b,c   Delestrain, Celine ^a   Louha, Malek ^d   Simon, Stephanie ^a,b   Fanen, Pascale ^a,b   Tazi, Abdellatif ^e,f  

^a INSERM U955   (France)

^b UNIVERSITÉ PARIS EST CRÉTEIL   (France)

^c CENTRE HOSPITALIER INTERCOMMUNAL DE CRÉTEIL   (France)

^d AP HP   (France)

^e UNIVERSITÉ PARIS DESCARTES   (France)

^f ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ATP-BINDING CASSETTE TRANSPORTERS; HETEROZYGOTE; HUMANS; LUNG; MALE; MUTATION; PHENOTYPE; PULMONARY EMPHYSEMA; PULMONARY FIBROSIS; PULMONARY SURFACTANT-ASSOCIATED PROTEIN C; PULMONARY SURFACTANTS; SYNDROME; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84893461810     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00145213     Document Type: Letter

References (10)

1. Deutsch GH, Young LR, Deterding RR, et al. Diffuse lung disease in young children: application of a novel classification scheme. Am J Respir Crit Care Med 2007; 176: 1120-1128.
2. Cottin V, Nunes H, Brillet PY, et al. Combined pulmonary fibrosis and emphysema: a distinct under recognised entity. Eur Respir J 2005; 26: 586-593.
3. Cottin V, Reix P, Khouatra C, et al. Combined pulmonary fibrosis and emphysema syndrome associated with familial SFTPC mutation. Thorax 2011; 66: 918-919.
4. Flamein F, Riffault L, Muselet-Charlier C, et al. Molecular and cellular characteristics of ABCA3 mutations associated with diffuse parenchymal lung diseases in children. Hum Mol Genet 2011; 21: 765-775.
5. Cheong N, Madesh M, Gonzales LW, et al. Functional and trafficking defects in ATP binding cassette A3 mutants associated with respiratory distress syndrome. J Biol Chem 2006; 281: 9791-9800.
6. Matsumura Y, Ban N, Ueda K, et al. Characterization and classification of ATP-binding cassette transporter ABCA3 mutants in fatal surfactant deficiency. J Biol Chem 2006; 281: 34503-34514.
7. Matsumura Y, Ban N, Inagaki N. Aberrant catalytic cycle and impaired lipid transport into intracellular vesicles in ABCA3 mutants associated with nonfatal pediatric interstitial lung disease. Am J Physiol Lung Cell Mol Physiol 2008; 295: L698-L707.
8. Wambach JA, Wegner DJ, Depass K, et al. Single ABCA3 mutations increase risk for neonatal respiratory distress syndrome. Pediatrics, 130: e1575-e1582.
9. Bullard JE, Nogee LM. Heterozygosity for ABCA3 mutations modifies the severity of lung disease associated with a surfactant protein C gene (SFTPC) mutation. Pediatr Res 2007; 62: 176-179.
10. Thouvenin G, Nathan N, Epaud R, et al. Diffuse parenchymal lung disease caused by surfactant deficiency: dramatic improvement by azithromycin. BMJ Case Rep 2013 [in press DOI: 10.1136/bcr-2013-009988].